BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35944043)

  • 1. Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
    Yang Z; Zhang Y; Stubbe-Espejel A; Zhao Y; Liu M; Li J; Zhao Y; Tong G; Liu N; Qi L; Hutchins A; Lin S; Li Y
    PLoS One; 2022; 17(8):e0270521. PubMed ID: 35944043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.
    Nieves-Ramírez ME; Partida-Rodríguez O; Moran P; Serrano-Vázquez A; Pérez-Juárez H; Pérez-Rodríguez ME; Arrieta MC; Ximénez-García C; Finlay BB
    Microbiol Spectr; 2021 Oct; 9(2):e0014321. PubMed ID: 34643408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
    Zhang W; Yin Y; Jiang Y; Yang Y; Wang W; Wang X; Ge Y; Liu B; Yao L
    J Transl Med; 2024 Apr; 22(1):396. PubMed ID: 38685022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Vaginal Microbiota Composition Correlates With Human Papillomavirus and Mucosal Immune Responses in Women With Symptomatic Cervical Ectopy.
    López-Filloy M; Cortez FJ; Gheit T; Cruz Y Cruz O; Cruz-Talonia F; Chávez-Torres M; Arteaga-Gómez C; Mancilla-Herrera I; Montesinos JJ; Cortés-Morales VA; Aguilar C; Tommasino M; Pinto-Cardoso S; Rocha-Zavaleta L
    Front Cell Infect Microbiol; 2022; 12():884272. PubMed ID: 35656032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
    Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
    Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-κB/C-myc.
    Dong B; Huang Y; Cai H; Chen Y; Li Y; Zou H; Lin W; Xue H; Feng A; Zhao H; Lu Y; Gao H; Mao X; Wu Z; Pan D; Sun P
    J Med Virol; 2022 Nov; 94(11):5519-5534. PubMed ID: 35835717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection.
    Mei L; Wang T; Chen Y; Wei D; Zhang Y; Cui T; Meng J; Zhang X; Liu Y; Ding L; Niu X
    J Transl Med; 2022 Jan; 20(1):12. PubMed ID: 34980148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
    Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
    BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis.
    Lin W; Zhang Q; Chen Y; Dong B; Xue H; Lei H; Lu Y; Wei X; Sun P
    Sci Rep; 2022 Feb; 12(1):2812. PubMed ID: 35181685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
    Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.
    Dareng EO; Ma B; Famooto AO; Adebamowo SN; Offiong RA; Olaniyan O; Dakum PS; Wheeler CM; Fadrosh D; Yang H; Gajer P; Brotman RM; Ravel J; Adebamowo CA
    Epidemiol Infect; 2016 Jan; 144(1):123-37. PubMed ID: 26062721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
    Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
    Front Public Health; 2020; 8():587298. PubMed ID: 33490017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions.
    Mitra A; MacIntyre DA; Ntritsos G; Smith A; Tsilidis KK; Marchesi JR; Bennett PR; Moscicki AB; Kyrgiou M
    Nat Commun; 2020 Apr; 11(1):1999. PubMed ID: 32332850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis.
    Bik EM; Bird SW; Bustamante JP; Leon LE; Nieto PA; Addae K; Alegría-Mera V; Bravo C; Bravo D; Cardenas JP; Carson GA; Caughey A; Covarrubias PC; Pérez-Donoso J; Gass G; Gupta SL; Harman K; Hongo DMB; Jiménez JC; Kraal L; Melis-Arcos F; Morales EH; Morton A; Navas CF; Nuñez H; Olivares E; Órdenes-Aenishanslins N; Ossandon FJ; Phan R; Pino R; Soto-Liebe K; Varas I; Vera-Wolf P; Walton NA; Almonacid DE; Goddard AD; Ugalde JA; Zneimer S; Richman J; Apte ZS
    PLoS One; 2019; 14(5):e0215945. PubMed ID: 31042762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China.
    Zhang Z; Li T; Zhang D; Zong X; Bai H; Bi H; Liu Z
    BMC Microbiol; 2021 Mar; 21(1):90. PubMed ID: 33765914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
    Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
    EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection.
    Andrade Pessoa Morales J; Marconi C; El-Zein M; Ravel J; da Silva Pinto GV; Silveira R; Lima MD; de Carvalho NS; Alves RRF; de Lima Parada CMG; Leite SHM; Villa LL; Franco EL; da Silva MG
    J Infect Dis; 2022 Sep; 226(6):1084-1097. PubMed ID: 34718662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in vaginal microbiome after focused ultrasound treatment of high-risk human papillomavirus infection-related low-grade cervical lesions.
    Wang W; Liu Y; Yang Y; Ren J; Zhou H
    BMC Infect Dis; 2023 Jan; 23(1):3. PubMed ID: 36604622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia.
    Mitra A; MacIntyre DA; Paraskevaidi M; Moscicki AB; Mahajan V; Smith A; Lee YS; Lyons D; Paraskevaidis E; Marchesi JR; Bennett PR; Kyrgiou M
    Genome Med; 2021 Nov; 13(1):176. PubMed ID: 34736529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.
    Brotman RM; Shardell MD; Gajer P; Tracy JK; Zenilman JM; Ravel J; Gravitt PE
    J Infect Dis; 2014 Dec; 210(11):1723-33. PubMed ID: 24943724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.